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Summary 
This report summarises and compares results from the proficiency test trial conducted by the 
National Food Institute (DTU Food) aiming at participants from the public health sector 
through the Food- and Waterborne Diseases and Zoonoses (FWD) programme of European 
Centre for Disease Prevention and Control (ECDC) as well as institutes from the veterinary/ 
food sector (NRL-AR). The objective was to evaluate the quality of the antimicrobial 
susceptibility data produced by the reference laboratories from the two networks. In addition, it 
was to identify areas which would require attention to produce reliable and harmonised 
susceptibility data.  
The assessment demonstrated that the AST-results obtained by the FWD-network and the 
EURL-AR-network are comparable as regards AST of Salmonella and Campylobacter. The 
acceptance level for deviations at 5% was met for five (55.6%) of the FWD-network 
laboratories and for 29 (85.3%) of the NRL-AR’s for Salmonella AST. For Campylobacter 
AST this was the case for nine (90%) of the FWD-network laboratories and for 22 (84.6%) of 
the NRL-AR’s. For both microorganisms room for improvement is demonstrated, and a 
repetition of this type of comparative testing therefore appears reasonable.  
The interpretation for ciprofloxacin posed a problem for the FWD-network laboratories. Many 
laboratories in this network perform disc diffusion (DD) for AST of Salmonella and as the 
interpretative criteria (epidemiological cut off value) applied in this proficiency test is much 
lower (R>0.064 µg/mL) than the clinical breakpoint (R≥4 µg/mL) and generated differences in 
interpretation. Also, the FWD-network laboratories to a large extent use diffusion tests for AST 
of Campylobacter and could present good agreement with the expected results using this 
method. However, for AST of this microorganism, the EURL-AR recommends MIC methods, 
only.   
Detection of ESBL-producing Enterobacteriaceae is relevant for both the public health 
laboratories and the laboratories from the veterinary/food sector as these phenotypes continue 
to emerge worldwide. Laboratories which have not yet introduced tests to detect ESBL-
producing Enterobacteriaceae are therefore encouraged to prioritize this area. 
1. Introduction 
In this report, results are summarised and compared from the proficiency test trial conducted by 
the National Food Institute (DTU Food) as the EU Reference Laboratory for Antimicrobial 
Resistance (EURL-AR) aiming at two networks as participants, i.e. the Salmonella and 
Campylobacter laboratory contact points of the Food- and Waterborne Diseases and Zoonoses 
Network (FWD-network) under the coordination of European Centre for Disease Prevention 
and Control, and the EURL-AR network. The FWD-network consists of public health reference 
level laboratories, and the EURL-AR network consists of institutes from the veterinary/ food 
sector.  
Proficiency testing is considered an important tool for the production of reliable laboratory 
results of consistently good quality. This proficiency test focuses on Salmonella and 
Campylobacter and is the sixth External Quality Assurance System (EQAS) conducted for 
these microorganisms in the EURL-AR network. In 2011, the EURL-AR through internal 
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funding was able to offer the public health laboratories participation in the Salmonella and 
Campylobacter antimicrobial susceptibility testing (AST) EQAS. 
The objective of this EQAS was to assess and compare the quality of the antimicrobial 
susceptibility data produced by the reference laboratories and to identify areas which would 
require attention to produce reliable and harmonised susceptibility data.  
At the annual EQAS conducted by the EURL-AR, the goal is to have each laboratory 
performing AST with less than 5% incorrect interpretations (interpretations deviating from the 
expected results). This performance criterion has also been applied for the present report. 
Evaluation in detail of the obtained results is presented in separate reports for each of the two 
networks and is therefore not the objective for the present report. This report will focus on the 
comparison of the obtained results between the two networks, i.e. between the public health 
sector and the veterinary-/food sector. 
The data in this report are presented with laboratory codes. A laboratory code is known to the 
individual laboratory, whereas the entire list of laboratories and their codes is confidential. All 
conclusions are public.  
Participants of an EQAS are expected to evaluate their own results and introduce corrective 
actions if necessary. The categorization of an uploaded interpretation as incorrect in the EURL-
AR EQAS should induce the participant to perform a self-evaluation. This self-evaluation 
could very well include a comment on the fact that an acceptable deviation for 
MIC‐determination is ± one dilution step, which in some cases may affect the interpretation of 
the result. Therefore, the self-evaluation may lead to arguments which can defend the obtained 
results internally, yet, incorrect interpretations based on a one step dilution difference is still 
regarded as a deviation for the overall EQAS reporting, evaluation and in the database. 
The EURL-AR is accredited by DANAK (accreditation no. 516) as provider of proficiency test 
for zoonotic pathogens and indicator organisms in bacterial isolates (serotyping, identification, 
and antimicrobial susceptibility testing). 
2. Materials and methods 
Detailed materials and methods are described in each of the network reports (1, 2). 
From the EURL-AR-network, 30 countries delivered 34 sets of Salmonella results and 26 sets 
of Campylobacter results, and from the FWD-network, 10 countries delivered 9 sets of 
Salmonella results and 10 sets of Campylobacter results (App. 1). 
Figure 1 illustrates that from eight countries both laboratories from the public health and from 
the veterinary/food sector participated, from 22 and two countries, respectively, laboratories 
from the veterinary/food sector and the public health sector, only, participated.  
Eight Salmonella strains and eight Campylobacter strains were selected for this trial among 
isolates from the strain collection at DTU Food. Individual sets of the Salmonella strains were 
provided as agar stab cultures and the Campylobacter strains as charcoal swabs. The process of 
preparation, assigning expected values, verification of expected values and shipment handling 
is described in detail in the EURL-AR network report (1). 
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The selection of antimicrobials used in the trial for Salmonella was: ampicillin, cefotaxime, 
cefotaxime/clavulanic acid, ceftazidime, ceftazidime/clavulanic acid, ceftiofur, 
chloramphenicol, ciprofloxacin, gentamicin, nalidixic acid, streptomycin, sulfonamides 
(sulfamethoxazole), tetracycline and trimethoprim. Additionally, cefoxitin was used for 
detection of ampC, and imipenem, imipenem/EDTA for detection of metallo-beta-lactamases. 
 
 
Figure 1: Countries from each of the networks participating in the antimicrobial susceptibility testing 
EQAS of Salmonella and/or Campylobacter.  
For Campylobacter the following antimicrobials were included: chloramphenicol, 
ciprofloxacin, erythromycin, gentamicin, nalidixic acid, streptomycin, and tetracycline.  
In this EQAS, the interpretative criteria which should be used were cut-off values 
recommended by the European Food Safety Authority (EFSA) and listed in the protocol (1). 
The participants from the EURL-AR network were instructed to use the method carried out 
when performing monitoring for EFSA, whereas the participating public health laboratories 
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could perform the AST using their method routinely employed in their laboratory. In general, 
participants using DD and E-test were recommended to interpret their results according to their 
individual routine, categorising the test strains into the terms resistant and susceptible. A 
categorisation as ‘intermediate’ was not accepted.  
In general, agar and broth dilution methods are considered the gold standard as regards 
antimicrobial susceptibility testing, and the EURL-AR recommends using these methods when 
performing AST. For Campylobacter, the EURL-AR does not recommend the use of either disk 
diffusion or E-test for AST; i.e. the only type of method recommendable for AST of 
Campylobacter is MIC methods. According to the protocol, the laboratories of the FWD-
network could submit results of AST of Campylobacter obtained by in-house methods like disk 
diffusion or E-test, in which cases in-house interpretative criteria should be applied as 
described in the protocol. 
For the EURL-AR network, the detection of ESBL-producing strains was mandatory, whereas 
it was an optional part of the EQAS for the FWD-network laboratories.  
The participants were instructed to enter results from the quality control (QC) reference strains 
into the database for use as background for the analysis of the obtained results (see each of the 
network reports (1, 2)). The evaluated results would consist of MIC values or inhibition zone 
diameters in millimetres for the reference strain E. coli (ATCC 25922) and MIC values for C. 
jejuni (ATCC 33560). The results should be in agreement with the quality control ranges 
according to the relevant guidelines; i.e. the CLSI documents M31-A3 (2008) or M100-S21 
(2011); The Sensititre System (Trek Diagnostic Systems Ltd, UK); or E-tests (AB-Biodisk, 
Sweden). 
The database generated evaluation reports assessed the submitted results, describing all 
deviations from the expected. Deviations in the interpretation as resistant or susceptible were 
categorised as ‘incorrect’, as was also deviations in confirmation of an isolate as ESBL-
producer or ampC.  
There are two different types of interpretative criteria of results, clinical breakpoints and 
epidemiological cut-off values. The terms ‘susceptible’, ‘intermediate’ and ‘resistant’ should in 
principle be reserved for classifications made in relation to the therapeutic application of 
antimicrobial agents. When reporting data using epidemiological cut-off values, bacteria should 
be reported as ‘wild-type’ or ‘non-wild-type’ (3). Due to the different methods of AST used by 
the participants and also to simplify the interpretation of results, throughout this report, we will 
still maintain the terms susceptible and resistant, even in the cases where we are referring to 
wild-type and non-wild-type strains. The resistance profiles of the included test strains are 
available in each of the network reports (1, 2). 
The database included questions for evaluation of the EQAS as well as questions regarding the 
individual laboratories’ work in the area of AST. Few laboratories made use of this possibility 
of sending comments to the EURL-AR; those who did have received direct reply when 
relevant.  
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3. Results and discussion 
The reported results included MIC values or inhibition zone diameters obtained by disk 
diffusion (DD) together with the categorisation as resistant or susceptible. Only the 
categorisation was evaluated, whereas the MIC values and disk diffusion inhibition zones were 
used as supplementary information. 
The EURL-AR network has agreed that if less than 75% of the results were correct, based on 
strain/antimicrobial combination, these results should be further analysed and possibly omitted 
from evaluation. In the present EQAS this occurred in two cases which both were omitted from 
evaluation: for the combination of the test strains S-6.2/streptomycin and S-6.6/streptomycin 
with a level of agreement with the expected results at 55% and 48%, respectively, when 
assessing the results obtained by the EURL-AR network. Consequently, all results from these 
two strain/antimicrobial combinations have also been omitted in this analysis. 
The methods listed in Table 1 were used for AST by the laboratories of the FWD-network and 
the EURL-AR-network.  
 
Table 1: Number of laboratories using each method for AST in this proficiency test 
 
Salmonella Campylobacter 
MIC 
determination E-test 
Disk 
diffusion 
MIC 
determination 
In-house  
E-test 
In-house  
disk diffusion 
ECDC FWD network 1 1 7 2 6 2 
EURL-AR network 28 - 6 26 - (1)* 
* Results disregarded in this report as the method is not accepted for Campylobacter in the EURL-AR network 
 
      
Figure 2: A comparison between the results obtained by the FWD-network and the EURL-AR network 
showing the total percentage of deviations for AST performed by participating laboratories 
The percentages of deviations from the expected results of AST performed by laboratories from 
each of the networks are illustrated in Figure 2. As indicated, both results obtained by each of 
the networks are well below the 5% acceptance level.  
Figures 3 and 4 illustrate the total percentage of deviations from the expected results obtained 
by the different methods performed, divided between each of the networks for AST’s 
performed on Salmonella and Campylobacter test strains, respectively.  
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Interestingly, the deviation levels for the Salmonella AST are exactly the same for MIC 
determination/EURL-AR-network and E-test/FWD-network, as well as the level of deviations 
for disk diffusion AST performed by each of the networks. For the EURL-AR network, a 
significant difference (χ2-test; p<0.01) was obtained when comparing results obtained by the 
use of disk diffusion and a MIC method. For the FWD-network, the comparison of the MIC-
determination and the disk diffusion method also rendered a significant difference (χ2-test; 
p<0.1). In both cases the MIC-determination exhibiting the better result.  
         
Figure 3: The percentage of deviations (number of deviations relative to the total tests performed) for 
AST’s of Salmonella test strains performed using each of the available methods. 
For the Campylobacter AST, the levels or deviation are fairly close as regards the use of MIC 
determination. Only the FWD-network made use of E-test and disk diffusion for the AST of 
Campylobacter, and a comparison of the results obtained by the MIC method (both networks) 
shows no significant difference neither to those obtained by E-test (p=0.4) nor to those obtained 
by disk diffusion (p=0.3).  
 
Figure 4: The percentage of deviations for AST’s of Campylobacter test strains performed using each of 
the available methods.  
As for the recommendation by the EURL-AR that the only type of method recommendable for 
AST of Campylobacter is MIC methods, i.e. broth or agar dilution methods, this is based on the 
fact that internationally recommended interpretative criteria are available for broth and agar 
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dilution methods, only. These methods have been validated and are recommended by CLSI 
(Clinical and Laboratory Standards Institute; www.clsi.org) and EUCAST (European 
Committee on Antimicrobial Susceptibility Testing; www.eucast.org), whereas for the 
diffusion methods (E-test and disk diffusion) there is for the moment no international 
references for quality assurance and interpretative criteria.  
Figures 5 and 6 illustrate the total percentage of deviations from the expected results obtained 
by each of the laboratories divided between each of the networks for AST’s performed on 
Salmonella and Campylobacter test strains, respectively. The laboratories are ranked according 
to their performance determined by the percentage of deviating results in tests including all 
antimicrobials but excluding ESBL confirmatory tests.  
Assessing results obtained by both networks, the deviation level for the Salmonella AST is 
generally low, with no laboratories exhibiting outlying levels, and with 34 laboratories (79%) 
performing acceptably according to the acceptance level at 5%.  
 
Figure 5: Individual participants’ deviations in percent of their total number of Salmonella AST’s. 
Laboratory numbers below 100 belong to the EURL-AR-network, whereas laboratory numbers from 101-
111 are indicated with an asterisk and belong to the FWD-network 
For the Campylobacter AST, 31 (86%) laboratories submitted results which meet the 
acceptance level (<5%), but of the five laboratories with a higher deviation level, one 
laboratory (#4) counted for 38% of all deviations in the EURL-AR-network. The laboratory has 
informed the EQAS organizer, that there were some personnel issues which have been handled 
right away. Laboratory #19 also counted for a large number of deviations, and communicated 
to the EQAS organizer that they are investigating the reason for these. 
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Figure 6: Individual participants’ deviations in percent of their total number of Campylobacter AST’s. 
Laboratory numbers below 100 belong to the EURL-AR-network, whereas laboratory numbers from 101-
111 are indicated with an asterisk and belong to the FWD-network. 
Figures 7 and 8 illustrate the total percentage of deviations from the expected results on each of 
the antimicrobials divided between each of the networks for AST’s performed on Salmonella 
and Campylobacter test strains, respectively.   
For Salmonella, ciprofloxacin clearly shows the highest deviation level for the FWD-network 
laboratories (27.8%), and also for the EURL-AR-network (5.7%). The interpretative criteria 
listed in the protocol refer to EUCAST where the cut off value for this antimicrobial is 0.06 
µg/mL. Many of the FWD-network laboratories submitted incorrect interpretations as 
susceptible, as this epidemiological cut off value is considerably lower than the clinical 
breakpoint set by CLSI (R≥4 µg/mL), and as no corresponding zone diameter is available. Two 
of the Salmonella strains harboured a plasmid-mediated quinolone resistance (PMQR) gene (S-
6.3/qnrB and S-6.7/qnrD) and thus exhibit nalidixic acid susceptibility and low-level 
ciprofloxacin resistance, the latter not being detectable when applying the routine CLSI 
methods and guidelines. The consequence of obtaining an incorrect interpretation in this 
EQAS, i.e. when applying the epidemiological cut off values for interpretation, is however not 
necessarily an incorrect interpretation in a clinical context. When analysing according to 
epidemiological cut off values, it is, however, recommended that laboratories performing disk 
diffusion for AST of Salmonella refer to the publication by Cavaco and Aarestrup, 2009 (4), 
which describes suggestions for disk content and cut off values for AST by disk diffusion of 
Salmonella isolates harbouring a PMQR-gene.  
For the Salmonella AST, the FWD-network and the EURL-AR-network, respectively, on 
average tested 9.8 and 10.6 antimicrobials per test strain. A number of the laboratories from the 
FWD-network did not test ceftiofur (veterinary antimicrobial) and ceftazidime, and the same 
was the case for the ceftiofur for the EURL-AR-network. 
Generally, since only interpretations as resistant or susceptible could be submitted, the 
laboratories performing disk diffusion for AST should refer to the comment in the protocol that 
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intermediary results should be interpreted as susceptible. For the FWD-network laboratories, 
this would have eliminated 4 (15%) of the deviations for the Salmonella test strains, as these 
particular results would be ‘intermediate’ if applying the CLSI guidelines. 
 
Figure 7: The percentage of deviations on each of the antimicrobials for AST’s performed on Salmonella 
test strains. Above each bar, the numerator and denominator are given. 
For Campylobacter, the FWD-network laboratories demonstrated 5 (1.2%) deviations, all of 
which were interpretations as resistant of MIC-values that according to the interpretative 
criteria in the protocol would be susceptible; two laboratories each counted for three and two of 
these deviations. As for the EURL-AR-network, the deviations (n=34; 2.5%) were to a large 
extent (n=13; 38% of Campylobacter AST deviations) caused by one laboratory due to 
personnel issues. This laboratory presented deviations for six of the seven antimicrobials. 
 
Figure 8: The percentage of deviations on each of the antimicrobials for AST’s performed on 
Campylobacter test strains. Above each bar, the numerator and denominator are given. 
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Only some laboratories from the FWD-network tested the Campylobacter test strains towards 
streptomycin (n=4) and chloramphenicol (n=5), and in total, the FWD-network and the EURL-
AR-network on average tested 5.0 and 6.6 antimicrobials per test strain, respectively. 
Figures 9 and 10 illustrate the total percentage of deviations from the expected results obtained 
for each of EQAS test strains divided between each of the networks for AST’s performed on 
Salmonella and Campylobacter test strains, respectively. The resistance phenotype of each of 
the strains is indicated.  
 
Figure 9: The percentage of deviations on each of the test strains for AST’s performed on Salmonella test 
strains. When a strain exhibited resistance to a certain antimicrobial it is indicated by an antimicrobial code; 
i.e. AMP, ampicillin; CTX, cefotaxime; FOX, cefoxitin; CAZ, ceftazidime; XNL, ceftiofur; CHL, 
chloramphenicol; CIP, ciprofloxacin; GEN, gentamicin; NAL, nalidixic acid; STR, streptomycin; SMX, 
sulphonamides; TET, tetracycline; and TMP, trimethoprim.  
For Salmonella, three strains cause very few deviations or none (S-6.1, S-6.6, S-6.8). Four 
strains accounted for most deviation for both the networks; i.e. S-6.2, S-6.3, S-6.4 and S-6.7. 
All of these strains exhibit reduced susceptibility to ciprofloxacin which is the cause of most of 
the deviating results.  
For Campylobacter, the five deviations from the FWD-network laboratories belong to three 
strains (C-6.6, C-6.7, C-6.8), whereas for the EURL-AR-network, the deviations are spread 
over seven of the eight test strains with one laboratory contributing to the deviations for six of 
the eight test strains. 
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Figure 10: The percentage of deviations on each of the test strains for AST’s performed on Campylobacter 
test strains. For each of the strains, a resistance phenotype is indicated by an antimicrobial code; i.e. CHL, 
chloramphenicol; CIP, ciprofloxacin; ERY, erythromycin; GEN, gentamicin; NAL, nalidixic acid; STR, 
streptomycin; and TET, tetracycline. 
ESBL-producing Salmonella test strains 
For the EURL-AR network, the detection of ESBL-producing strains was mandatory, whereas 
it was an optional part of the EQAS for the ECDC FWD-network laboratories. The details of 
the ESBL-detection and confirmation are addressed in the EURL-AR report (1).  
Four test strains; S-6.1, S-6.3, S-6.4 and S-6.8 were ESBL-producers, i.e. three were so-called 
‘true ESBLs’, harbouring blaTEM-52 (S-6.1), blaCTX M-15 and blaSHV-12 (S-6.3) and blaCTX M-15 (S-
6.4), whereas one was and ampC-producing strain harbouring blaCMY-2 (S-6.8). 
The ESBL-production was confirmed by the majority (n=32, 32, 32 and 31 for the strains S-
6.1, S-6.3, S-6.4 and S-6.8) of the 34 laboratories from the EURL-AR network participating in 
the Salmonella EQAS. Of the nine FWD-network laboratories submitting results on the 
Salmonella test strains, six participated in the ESBL component and all of these submitted 
correct results on the confirmation of ESBL-production except one laboratory, which 
incorrectly categorised the ampC-producing strain (S-6.8) as ESBL-producer. All nine 
laboratories tested the Salmonella test strains towards at least one cephalosporin, and five 
included testing of susceptibility towards cefoxitin for selected test strains (n=4) or for all eight 
Salmonella test strains (n=1). 
Deviations by reference strains  
In the following section, deviations are defined as results of antimicrobial susceptibility tests on 
the reference strain that are outside the quality control (QC) acceptance intervals (App. 2). All 
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laboratories from the FWD-network submitted results for the quality control of the method 
relevant for both the Salmonella (9 laboratories) and the Campylobacter (8 laboratories) 
testing. For the EURL-AR, all 26 laboratories performing MIC for AST of Campylobacter, and 
all 34 laboratories submitting MIC-results for Salmonella uploaded QC-strain results. Five of 
the six NRL-AR’s performing disk diffusion for AST of Salmonella uploaded QC-results. 
The results from the reference strain should be assessed as part of the quality assurance of the 
values obtained when performing AST on the test strains, and are therefore especially 
important for laboratories which have deviations listed in their evaluation report. The obtained 
values for the QC-reference strains are further evaluated in the separate reports for each of the 
two networks.  
The submitted results from testing the C. jejuni reference strain could be evaluated for two of 
the nine FWD-network laboratories, as the remaining uploaded values were E-test MIC-values 
and inhibition zone diameters where no evaluation criteria is available. 
4. Conclusions 
The objective of providing the EURL-AR EQAS to the FWD-network this year, was to assess 
and compare the quality of the antimicrobial susceptibility data produced by the reference 
laboratories from the two networks. In addition, it was to identify areas which would require 
attention to produce reliable and harmonised susceptibility data.  
This assessment demonstrates that the AST-results obtained by the FWD-network and the 
EURL-AR-network are comparable as regards AST of Salmonella and Campylobacter. The 
goal as to acceptance level for deviations for each laboratory was set at 5%. This goal was met 
for 5 (55.6%) of the FWD-network laboratories and for 29 (85.3%) of the NRL-AR’s for 
Salmonella AST. For Campylobacter AST this was the case for 9 (90%) of the FWD-network 
laboratories and for 22 (84.6%) of the NRL-AR’s. 
The EURL-AR recommends MIC methods, only, i.e. broth or agar dilution methods, for AST 
of Campylobacter due to the fact that for the diffusion methods there are for the moment no 
international references for quality assurance and interpretative criteria. In this EQAS, 
however, no deviations were detected when disc diffusion was applied for the AST of 
Campylobacter. 
Especially for the FWD-network laboratories, the interpretation of ciprofloxacin posed a 
problem. Many laboratories in this network perform DD for AST of Salmonella and as this 
breakpoint is much lower than the clinical breakpoint, this generates a difference in 
interpretation. 
The issue about detection of ESBL-producing Enterobacteriaceae is critically relevant for both 
the public health laboratories and the laboratories from the veterinary/food sector as these 
phenotypes appear to continue to emerge worldwide. Laboratories which have not yet 
introduced tests to detect ESBL-producing Enterobacteriaceae are therefore encouraged to 
prioritize this area. 
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Appendix 1, page 1 of 1
Participant list
Salmonella Campylobacter Sector Institute  Country
X X Veterinary/Food Austrian Agency for Health and Food Safety Austria
X X Veterinary/Food Institute of Public Health Belgium
X - Veterinary/Food Nacional Diagnostic and Research Veterinary Institute Bulgaria
X - Veterinary/Food Croatian Veterinary Institut Croatia
X X Veterinary/Food Veterinary Services Cyprus
X X Veterinary/Food State Veterinary Institute Praha Czech Republic
X X Veterinary/Food The National Food Institute Denmark
Public Health Statens Serum Institut Denmark
X X Veterinary/Food Estonian Veterinary and Food Laboratory Estonia
X X Veterinary/Food Finnish Food Safety Authority EVIRA Finland
Public Health National Institute for Health and Welfare (THL) Finland
X - Veterinary/Food ANSES Maisons Alfort France
- X Veterinary/Food ANSES Ploufragan France
X - Veterinary/Food ANSES Lyon France
X - Veterinary/Food ANSES Fougères France
Public Health Hôpital Pellegrin France
X X Veterinary/Food Federal Institute for Risk Assessment Germany
X - Veterinary/Food Veterinary Laboratory of Chalkis Greece
X X Veterinary/Food Central Agricultural Office, Veterinary Diagnostical Directorate Hungary
Public Health National Center for Epidemiology Hungary
Public Health Landspitali University Hospital Iceland
X X Veterinary/Food Central Veterinary Research Laboratory Ireland
X - Veterinary/Food Istituto Zooprofilattico Sperimentale delle Regioni Lazio e Toscana Italy
X X Veterinary/Food Institute of Food Safety, Animal Health and Environment „BIOR” Latvia
X X Veterinary/Food National Food and Veterinary Risk Assessment Institute Lithuania
Public Health Laboratoire National de Santé Luxembourg
X X Veterinary/Food Public Health Laboratory Malta
X X Veterinary/Food Central Veterinary Institute of Wageningen UR Netherlands
X X Veterinary/Food Veterinærinstituttet Norway
Public Health Norwegian Institute of Public Health Norway
X X Veterinary/Food National Veterinary Research Institute Poland
Public Health Institute of Public Health - National Institute of Hygiene (NIZP-PZH) Poland
X X Veterinary/Food Laboratorio National de Investigacáo Veterinaria Portugal
X X Veterinary/Food Institute for Hygiene and Veterinary Public Health Romania
X - Veterinary/Food Institute of Veterinary Medicine of Serbia Serbia
X X Veterinary/Food State Veterinary and Food Institute  (SVFI) Slovakia 
X X Veterinary/Food National Veterinary Institute Slovenia
Public Health ZAVOD ZA ZDRAVSTVENO VARSTVO NOVA GORICA Slovenia
Public Health Institute of Public Health of the Republic of Slovenia Slovenia
- - Veterinary/Food Laboratorio Central de Sanidad, Animal de Santa Fe (only Staph) Spain
X X Veterinary/Food Laboratorio Central de Sanidad, Animal de Algete Spain
X - Veterinary/Food Centro nacional de Alimentacion. Agencia Espanola de Seguridad 
Ali t i   N t i i
Spain
Public Health Instituto de Salud Carlos III (ISCIII) Spain
X X Veterinary/Food National Veterinary Institute, SVA Sweden
X X Veterinary/Food Vetsuisse faculty Bern, Institute of veterinary bacteriology Switzerland
X X Veterinary/Food The Veterinary Laboratory Agency United Kingdom
X X Veterinary/Food Centre for Infections Health Protection Agency United Kingdom
Designated NRL-AR by the compentent authority of the member state
Not a Member State of the EU
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QC ranges for reference strains
Antimicrobial MIC E-test
Ampicillin, AMP 2-8 2-8
Cefotaxime, CTX 0.03-0.12 0.03-0.12
Cefoxitin, FOX 2-8 None
Ceftazidime, CAZ 0.06-0.5 0.06-0.5
Ceftiofur, XNL 0.25-1 None
Chloramphenicol, CHL 2-8 None
Ciprofloxacin, CIP 0.004-0.016 None
Gentamicin, GEN 0.25-1 None
Imipenem, IMI 0.06-0.25 0.06-0.25
Nalidixic acid, NAL 1-4 1-4
Streptomycin, STR 4-16 2-8
Sulfisoxazole, FIS 8-32 32-128
Tetracycline, TET 0.5-2 0.5-2
Trimethoprim, TMP 0.5-2 0.5-2
E-test ranges are according to AB-Biodisk
Antimicrobial Microbroth                
(36-37°C/48h)
Microbroth 
(42°C/24h)
Agar dilution     
(36-37°C/48h)
Agar dilution     
(42°C/24h)
Chloramphenicol, CHL 1-8 1-4 None None
Ciprofloxacin, CIP 0.06-0.25 0.03-0.12 0.12-1 0.06-0.5
Erythromycin, ERY 0.5-2 0.25-2 1-8 1-4
Gentamicin, GEN 0.5-2 0.25-2 0.5-2 0.5-4
Nalidixic acid, NAL 4-16 4-16 None None
Tetracycline, TET 0.25-2 0.25-1 None None
25-32 (30µg)
26-31 (30µg)
21-27 (30µg)
21-28 (5µg)
MIC ranges and disc diffusion ranges are according to CLSI M100 S21 with the following exceptions: 
The MIC range for streptomycin is according to Sensititre and the range for ceftiofur is according to 
M31-A3. Additionally, the range for ciprofloxacin is extended to include 0.016 as well.
22-28 (30µg)
12-20 (10µg)
15-23 (250/300µg)
30-40 (5µg)
E. coli ATCC 25922
DD (disc content)
16-22 (10µg)
29-35 (30µg)
23-29 (30µg)
19-26 (10µg)
26-32 (10µg)
18-25 (30µg)
Ranges are according to CLSI (M31-A3) 
Campylobacter jejuni ATCC 33560
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